Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
IQ-AI Limited (GB:IQAI)
LSE:IQAI
IQ-AI Limited (IQAI) Share Price & Analysis
5 Followers
IQAI Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range0.93p - 5.80p
Previous Close1.3p
Volume190.47K
Average Volume (3M)590.76K
Market Cap
£2.88M
Enterprise Value2.57M
Total Cash (Recent Filing)£313.99K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.50
Next Earnings
Sep 16, 2024EPS EstimateN/A
Last Dividend Ex-Date
Apr 06, 2011Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding221,709,789
10 Day Avg. Volume1,822,565
30 Day Avg. Volume590,756
Standard Deviation0.51
R-Squared0.10
Alpha0.12
Financial Highlights & Ratios
Price to Book (P/B)-10.62
Price to Sales (P/S)6526.06
Price to Cash Flow (P/CF)-5.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
IQ-AI Limited News
PremiumCompany Announcements
IQ-AI Unveils Early Access Brain Tumor Treatment
PremiumCompany Announcements
IQ-AI Limited Advances Promising Cancer Drug
PremiumCompany Announcements
IQ-AI’s IB Nimble Revolutionizes Brain Cancer Care
PremiumCompany Announcements
IQ-AI’s Drug Earns Key FDA Pediatric Disease Status
PremiumCompany Announcements
IQ-AI Advances Medical Diagnostics with Swiss HospitalPremiumCompany Announcements
IQ-AI Subsidiary Earns FDA Pediatric Disease Designation
PremiumCompany Announcements
IQ-AI Subsidiary Launches Hopeful Brain Tumor Treatment Program
PremiumCompany Announcements
IQ-AI Limited Announces Revenue Growth and Strategic ProgressOptions Prices
Currently, No data available
---
Ownership Overview
31.66% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
68.34% Public Companies and
Individual Investors
IQAI FAQ
What was IQ-AI Limited’s price range in the past 12 months?
IQ-AI Limited lowest share price was 0.93p and its highest was 5.80p in the past 12 months.
What is IQ-AI Limited’s market cap?
Currently, no data Available
When is IQ-AI Limited’s upcoming earnings report date?
IQ-AI Limited’s upcoming earnings report date is Sep 16, 2024 which is in 54 days.
How were IQ-AI Limited’s earnings last quarter?
IQ-AI Limited released its earnings results on Apr 29, 2024. The company reported -0.002p earnings per share for the quarter, missing the consensus estimate of N/A by -0.002p.
Is IQ-AI Limited overvalued?
According to Wall Street analysts IQ-AI Limited’s price is currently Overvalued.
Does IQ-AI Limited pay dividends?
IQ-AI Limited pays a Notavailable dividend of 0.8p which represents an annual dividend yield of N/A. See more information on IQ-AI Limited dividends here
What is IQ-AI Limited’s EPS estimate?
IQ-AI Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IQ-AI Limited have?
IQ-AI Limited has 221,709,800 shares outstanding.
What happened to IQ-AI Limited’s price movement after its last earnings report?
IQ-AI Limited reported an EPS of -0.002p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of IQ-AI Limited?
Currently, no hedge funds are holding shares in GB:IQAI
---
IQ-AI Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.66%
12-Months-Change
Fundamentals
Return on Equity
-213.56%
Trailing 12-Months
Asset Growth
-43.14%
Trailing 12-Months
Company Description
IQ-AI Limited
IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on proven technologies. Its geographical segment includes Jersey and the United States of America. The company derives a majority of revenue from the United States of America. It also supplies medical technology solutions and has a strong neuroimaging product portfolio.
---
Technical Analysis
---